Cerebral PalsyNCT04081675
Compliance in Children With Cerebral Palsy Supplied With AFOs
An observational study of Cerebral Palsy, run by Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust at 1 site in United Kingdom.
Trial summary
Children with cerebral palsy are frequently supplied with Ankle Foot Orthoses (AFOs) to aid their walking. There are huge benefits to patients in staying physically active into adulthood but this becomes more challenging as children progress through adolescence. Read more about this study
- Who is it for?
- Ages 9 to 13 years
- Conditions the study is for
- Cerebral Palsy
- What is being tested?
- Ankle Foot Orthosis (AFO)
- Type of treatment
- Medical device
- How many people
- 4 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 30 Sep 2022to 30 Sep 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 9 to 13 years
- All sexes
- No healthy volunteers
- Child
Study population: Children with cerebral palsy
Who may be able to join
- Diagnosis of spastic diplegia or hemiplegia GMFCS level 1 or 2 (ie independently mobile) Gait pattern compatible with achieving clean foot strikes on the force platforms in the gait laboratory.
- Able to understand sufficiently to co-operate happily with the gait analysis process and participate in the interviews.
- In main stream education
Who cannot join
- Any behavioural or communication problems which would make them unable to comply with the protocol.
- Any invasive procedures (eg surgery, Botulinum toxin injections) in the previous 6 months.
- Any invasive procedures (eg surgery, Botulinum toxin injections) planned in the next 6 months.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
ORLAU, RJAH Orthopaedic Hospital
Oswestry, Shropshire, SY10 7AG
Caroline Stewart, PhD, 0044 1691 404666, caroline.stewart9@nhs.net
Teresa Jones, 0044 1691 404143, teresa.jones6@nhs.net
About this study
Official title: Understanding the Factors Affecting Compliance in Children With Cerebral Palsy Supplied With Ankle Foot Orthoses (AFOs) Using Quantitative Measurement of Function and Qualitative Evaluation of Experience and Wellbeing
Children with cerebral palsy are frequently supplied with Ankle Foot Orthoses (AFOs) to aid their walking. There are huge benefits to patients in staying physically active into adulthood but this becomes more challenging as children progress through adolescence. It is possible to measure the functional benefits of AFO use, however the investigators suspect the correlation with patient compliance is poor. By combining quantitative analysis using 3D gait analysis with qualitative exploration of children's experience the investigators hope to gain a better understanding of the factors influencing children's compliance. This compliance will be measured using sensors mounted in the AFOs, over a 3 month period. The investigators hope this research will help clinicians manage patients better and also inform changes in splint design.
Read the detailed description
Background
About 1 in 400 children born in the UK has cerebral palsy (CP). CP is caused by injury to the foetal or infant brain, and results in problems with walking, balance and coordination. One of the most common strategies for treating walking limitations in children with CP is the use of Ankle Foot Orthoses (AFOs), which aim to correct deformity and improve walking efficiency.
Keeping children with CP mobile is important, not only because physical fitness contributes to quality of life, but also because lack of physical activity can result in a downwards spiral: low physical fitness can make activities of daily living more difficult, leading to further reduction in activity and fitness. One study showed that children with CP at age 10 who walked and did not use a wheelchair had only a small chance (11%) of becoming non-ambulatory, vs. 34% of children using a wheelchair.
AFOs can play an important part in keeping children with CP mobile, and reducing the need for a wheelchair. However, there is evidence that when they reach adolescence, some children are reluctant to wear their AFOs. One of the parents participating in a previous study said "... now we have a 13-year-old who just wants to be like other 13- year-old girls, and she doesn't want to wear AFOs ...". Studies show that children with CP often lose functional ability through adolescence and early adulthood, but it is not clear how that relates to their use or non-use of prescribed AFOs. There are also many factors which contribute to compliance with clinical recommendation and a scarcity of research into the psychological elements which can impact on this, though research indicates that perception and empowerment can increase the likelihood of a successful intervention application and compliance rates.
In this application the investigators seek to explore both the objective, functional benefits of using AFOs and the subjective experience of children and their families. A combination of quantitative and qualitative approaches will be used to understand the factors affecting children's compliance.
Purpose, aims or hypothesis
The overall aim is to understand the factors affecting compliance in children with cerebral palsy using AFOs. The investigators propose to do this by combining quantitative measurement of functional benefit, with qualitative exploration of the patient's experience.
To achieve this the investigators will:- Phase 1: Measure the functional effect of AFOs using 3D movement analysis technology in four children (treated as case studies).
Phase 2: Record patient compliance in the same group of children using sensors embedded in the AFOs Phase 3: Interview children and their families to explore the experience of using assistive devices.
Experimental plan, methods, timetable:
Children with cerebral palsy will be recruited from the routine clinics in ORLAU, at the RJAH Orthopaedic Hospital. The investigators will aim to recruit 4 children with cerebral palsy who have been prescribed bilateral moulded AFOs, two from primary school years 5/6 (1F, 1M) and two from secondary school years 7-9 (1F, 1M). The children will be GMFCS level 1 or 2 and be in main stream education.
Phase 1: 3D movement analysis
Children will be measured by means of 3D movement analysis (Vicon) at their supply appointment. Markers will be placed on the lower limbs and pelvis using the Plug-in-Gait model. Children will be measured walking in shoes with and without their AFOs. The gait analysis will provide detailed quantification of angles and moments at each joint, however the primary measures will be walking speed and the collated GPS which gives an overall score of the deviation from normal walking.
A full clinical examination will also be performed, along with video film of their feet when walking barefoot to assess the extent of any foot deformity.
Phase 2: Assessment of compliance
Each AFO will be fitted with an Orthotimer (www.orthotimer.com) sensor before it is supplied. This data will be downloaded at the review appointment, when the interviews will also be conducted. The device stores data every 15 min for up to 100 days recording whether the orthosis is in use at a given time.
Phase 3: Interviews
Semi-structured interviews will take place with the children recruited for phase 1, asking questions which will allow them to discuss their experiences of living with CP and of using assistive devices, particularly within their school environment; participants in secondary school will be also be asked about their experience in primary school. Questions will be as open as possible to allow the child to give rich, detailed accounts of their day to day experiences and their perceptions of AFOs. The interviews should provide a broad understanding of individual experiences and perspectives of AFOs and reasons for compliance. All children and their families will be invited back to verify the themes from the interviews at a separate, non-clinical, visit. Themes from the school group sessions will be used to shape the questions.
A mapping exercise, based on previous research will be used to enhance the discussion and visually identify locations where the children use their AFOs, their feelings triggered by a range of environments, and any issues they may have with the orthotic devices. These maps can then be used to facilitate further discussion about the children's experiences and analysed alongside the Orthotimer data to develop an in-depth view of the children's use and perception of their AFOs.
- Conditions
- Cerebral Palsy
- Being tested
- Ankle Foot Orthosis (AFO)
- Keywords
- orthotics, gait analysis
- Medical subject headings
- Cerebral Palsy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Ankle Foot Orthosis (AFO)Device
Thermoplastic orthotic device spanning the calf, ankle and foot.
What is being measured
The primary outcome is the main question the study is designed to answer.
Walking speed (m/s)
This will be measured in a clinical movement analysis laboratory using timing gates at either end of the walkway.
Measured: At baseline
Gait Profile Score (GPS) in degrees
A 3D movement analysis system will be used to record the full kinematics and kinetics of the child's gait with and without AFOs. The outcome measure extracted will be the GPS, which documents the average deviation in joint angles (in degrees) across multiple joints compared with an unimpaired control cohort. Unimpaired data are already available in the host unit.
Measured: At baseline
Compliance (minutes per day)
The compliance will be recorded using Orthotimer sensors embedded in the body of the AFO. The sensors record usage throughout the day in 15min intervals.
Measured: At end of 3 months of use
Patient Experience
Qualitative interviews - an entirely qualitative approach will be used to draw out narrative themes. No scoring scale is used.
Measured: At end of 3 months of use
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Sep 2019
- Study start30 Sep 2022 (estimated)
- Primary completion30 Sep 2023 (estimated)
- Study completion30 Sep 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for Cerebral PalsyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 4 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
- Sponsor type
- Other government
- Collaborators
- Keele University, University of Nottingham
- Responsible party
- Sponsor
- Investigators
- Dr C Stewart, PhD, Principal investigator, RJAH Orthopaedic Hospital/Keele University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04081675
- Sponsor's protocol ID
- RL1796
- Status last verified
- Apr 2021
- First submitted
- 2 Sep 2019
- Last updated
- 22 Apr 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Andersson C, Mattsson E. Adults with cerebral palsy: a survey describing problems, needs, and resources, with special emphasis on locomotion. Dev Med Child Neurol. 2001 Feb;43(2):76-82. doi: 10.1017/s0012162201.
PubMed 11221908Butler PB, Farmer SE, Stewart C, Jones PW, Forward M. The effect of fixed ankle foot orthoses in children with cerebral palsy. Disabil Rehabil Assist Technol. 2007 Jan;2(1):51-8. doi: 10.1080/17483100600662009.
PubMed 19263554Day SM, Wu YW, Strauss DJ, Shavelle RM, Reynolds RJ. Change in ambulatory ability of adolescents and young adults with cerebral palsy. Dev Med Child Neurol. 2007 Sep;49(9):647-53. doi: 10.1111/j.1469-8749.2007.00647.x.
PubMed 17718819Gabb J, Singh R. The uses of emotion maps in research and clinical practice with families and couples: methodological innovation and critical inquiry. Fam Process. 2015 Mar;54(1):185-97. doi: 10.1111/famp.12096. Epub 2014 Aug 5.
PubMed 25091031Hayles E, Harvey D, Plummer D, Jones A. Parents' Experiences of Health Care for Their Children With Cerebral Palsy. Qual Health Res. 2015 Aug;25(8):1139-54. doi: 10.1177/1049732315570122. Epub 2015 Feb 23.
PubMed 25711842Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol. 2002 Sep;44(9):633-40.
PubMed 12227618Koldoff EA, Holtzclaw BJ. Physical Activity Among Adolescents with Cerebral Palsy: An Integrative Review. J Pediatr Nurs. 2015 Sep-Oct;30(5):e105-17. doi: 10.1016/j.pedn.2015.05.027. Epub 2015 Jul 18.
PubMed 26195302Krakovsky G, Huth MM, Lin L, Levin RS. Functional changes in children, adolescents, and young adults with cerebral palsy. Res Dev Disabil. 2007 Jul-Sep;28(4):331-40. doi: 10.1016/j.ridd.2006.03.005.
PubMed 16772110Nooijen C, Slaman J, van der Slot W, Stam H, Roebroeck M, van den Berg-Emons R; Learn2Move Research Group. Health-related physical fitness of ambulatory adolescents and young adults with spastic cerebral palsy. J Rehabil Med. 2014 Jul;46(7):642-7. doi: 10.2340/16501977-1821.
PubMed 24714702Wingstrand M, Hagglund G, Rodby-Bousquet E. Ankle-foot orthoses in children with cerebral palsy: a cross sectional population based study of 2200 children. BMC Musculoskelet Disord. 2014 Oct 2;15:327. doi: 10.1186/1471-2474-15-327.
PubMed 25274143
Study at a glance
From the registry record, last updated by the sponsor on 22 Apr 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Understanding the Factors Affecting Compliance in Children With Cerebral Palsy Supplied With Ankle Foot Orthoses (AFOs) Using Quantitative Measurement of Function and Qualitative Evaluation of Experience and Wellbeing
- ClinicalTrials.gov ID
- NCT04081675
- Acronym / sponsor ID
- RL1796
- Conditions
- Cerebral Palsy
- Keywords
- orthotics, gait analysis
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 4 participants (estimated)
- Lead sponsor
- Robert Jones and Agnes Hunt Orthopaedic and District NHS TrustOther government
- Collaborators
- Keele University, University of Nottingham
- Study start
- 30 Sep 2022 (estimated)
- Primary completion
- 30 Sep 2023 (estimated)
- Study completion
- 30 Sep 2023 (estimated)
- First posted
- 9 Sep 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Children with cerebral palsy are frequently supplied with Ankle Foot Orthoses (AFOs) to aid their walking. There are huge benefits to patients in staying physically active into adulthood but this becomes more challenging as children progress through adolescence. It is possible to measure the functional benefits of AFO use, however the investigators suspect the correlation with patient compliance is poor. By combining quantitative analysis using 3D gait analysis with qualitative exploration of children's experience the investigators hope to gain a better understanding of the factors influencing children's compliance. This compliance will be measured using sensors mounted in the AFOs, over a 3 month period. The investigators hope this research will help clinicians manage patients better and also inform changes in splint design.
Detailed description
Background
About 1 in 400 children born in the UK has cerebral palsy (CP). CP is caused by injury to the foetal or infant brain, and results in problems with walking, balance and coordination. One of the most common strategies for treating walking limitations in children with CP is the use of Ankle Foot Orthoses (AFOs), which aim to correct deformity and improve walking efficiency.
Keeping children with CP mobile is important, not only because physical fitness contributes to quality of life, but also because lack of physical activity can result in a downwards spiral: low physical fitness can make activities of daily living more difficult, leading to further reduction in activity and fitness. One study showed that children with CP at age 10 who walked and did not use a wheelchair had only a small chance (11%) of becoming non-ambulatory, vs. 34% of children using a wheelchair.
AFOs can play an important part in keeping children with CP mobile, and reducing the need for a wheelchair. However, there is evidence that when they reach adolescence, some children are reluctant to wear their AFOs. One of the parents participating in a previous study said "... now we have a 13-year-old who just wants to be like other 13- year-old girls, and she doesn't want to wear AFOs ...". Studies show that children with CP often lose functional ability through adolescence and early adulthood, but it is not clear how that relates to their use or non-use of prescribed AFOs. There are also many factors which contribute to compliance with clinical recommendation and a scarcity of research into the psychological elements which can impact on this, though research indicates that perception and empowerment can increase the likelihood of a successful intervention application and compliance rates.
In this application the investigators seek to explore both the objective, functional benefits of using AFOs and the subjective experience of children and their families. A combination of quantitative and qualitative approaches will be used to understand the factors affecting children's compliance.
Purpose, aims or hypothesis
The overall aim is to understand the factors affecting compliance in children with cerebral palsy using AFOs. The investigators propose to do this by combining quantitative measurement of functional benefit, with qualitative exploration of the patient's experience.
To achieve this the investigators will:- Phase 1: Measure the functional effect of AFOs using 3D movement analysis technology in four children (treated as case studies).
Phase 2: Record patient compliance in the same group of children using sensors embedded in the AFOs Phase 3: Interview children and their families to explore the experience of using assistive devices.
Experimental plan, methods, timetable:
Children with cerebral palsy will be recruited from the routine clinics in ORLAU, at the RJAH Orthopaedic Hospital. The investigators will aim to recruit 4 children with cerebral palsy who have been prescribed bilateral moulded AFOs, two from primary school years 5/6 (1F, 1M) and two from secondary school years 7-9 (1F, 1M). The children will be GMFCS level 1 or 2 and be in main stream education.
Phase 1: 3D movement analysis
Children will be measured by means of 3D movement analysis (Vicon) at their supply appointment. Markers will be placed on the lower limbs and pelvis using the Plug-in-Gait model. Children will be measured walking in shoes with and without their AFOs. The gait analysis will provide detailed quantification of angles and moments at each joint, however the primary measures will be walking speed and the collated GPS which gives an overall score of the deviation from normal walking.
A full clinical examination will also be performed, along with video film of their feet when walking barefoot to assess the extent of any foot deformity.
Phase 2: Assessment of compliance
Each AFO will be fitted with an Orthotimer (www.orthotimer.com) sensor before it is supplied. This data will be downloaded at the review appointment, when the interviews will also be conducted. The device stores data every 15 min for up to 100 days recording whether the orthosis is in use at a given time.
Phase 3: Interviews
Semi-structured interviews will take place with the children recruited for phase 1, asking questions which will allow them to discuss their experiences of living with CP and of using assistive devices, particularly within their school environment; participants in secondary school will be also be asked about their experience in primary school. Questions will be as open as possible to allow the child to give rich, detailed accounts of their day to day experiences and their perceptions of AFOs. The interviews should provide a broad understanding of individual experiences and perspectives of AFOs and reasons for compliance. All children and their families will be invited back to verify the themes from the interviews at a separate, non-clinical, visit. Themes from the school group sessions will be used to shape the questions.
A mapping exercise, based on previous research will be used to enhance the discussion and visually identify locations where the children use their AFOs, their feelings triggered by a range of environments, and any issues they may have with the orthotic devices. These maps can then be used to facilitate further discussion about the children's experiences and analysed alongside the Orthotimer data to develop an in-depth view of the children's use and perception of their AFOs.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 9 to 13 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
- Study population
- Children with cerebral palsy
Key inclusion criteria (3 listed)
- Diagnosis of spastic diplegia or hemiplegia GMFCS level 1 or 2 (ie independently mobile) Gait pattern compatible with achieving clean foot strikes on the force platforms in the gait laboratory.
- Able to understand sufficiently to co-operate happily with the gait analysis process and participate in the interviews.
- In main stream education
Key exclusion criteria (3 listed)
- Any behavioural or communication problems which would make them unable to comply with the protocol.
- Any invasive procedures (eg surgery, Botulinum toxin injections) in the previous 6 months.
- Any invasive procedures (eg surgery, Botulinum toxin injections) planned in the next 6 months.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Ankle Foot Orthosis (AFO)Thermoplastic orthotic device spanning the calf, ankle and foot. | Device | – |
Primary outcome
Walking speed (m/s)
Time frame: At baseline
This will be measured in a clinical movement analysis laboratory using timing gates at either end of the walkway.
Gait Profile Score (GPS) in degrees
Time frame: At baseline
A 3D movement analysis system will be used to record the full kinematics and kinetics of the child's gait with and without AFOs. The outcome measure extracted will be the GPS, which documents the average deviation in joint angles (in degrees) across multiple joints compared with an unimpaired control cohort. Unimpaired data are already available in the host unit.
Compliance (minutes per day)
Time frame: At end of 3 months of use
The compliance will be recorded using Orthotimer sensors embedded in the body of the AFO. The sensors record usage throughout the day in 15min intervals.
Patient Experience
Time frame: At end of 3 months of use
Qualitative interviews - an entirely qualitative approach will be used to draw out narrative themes. No scoring scale is used.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Apr 2021.
- Background: PubMed 11221908Andersson C, Mattsson E. Adults with cerebral palsy: a survey describing problems, needs, and resources, with special emphasis on locomotion. Dev Med Child Neurol. 2001 Feb;43(2):76-82. doi: 10.1017/s0012162201.
- Background: PubMed 19263554Butler PB, Farmer SE, Stewart C, Jones PW, Forward M. The effect of fixed ankle foot orthoses in children with cerebral palsy. Disabil Rehabil Assist Technol. 2007 Jan;2(1):51-8. doi: 10.1080/17483100600662009.
- Background: PubMed 17718819Day SM, Wu YW, Strauss DJ, Shavelle RM, Reynolds RJ. Change in ambulatory ability of adolescents and young adults with cerebral palsy. Dev Med Child Neurol. 2007 Sep;49(9):647-53. doi: 10.1111/j.1469-8749.2007.00647.x.
- Background: PubMed 25091031Gabb J, Singh R. The uses of emotion maps in research and clinical practice with families and couples: methodological innovation and critical inquiry. Fam Process. 2015 Mar;54(1):185-97. doi: 10.1111/famp.12096. Epub 2014 Aug 5.
- Background: PubMed 25711842Hayles E, Harvey D, Plummer D, Jones A. Parents' Experiences of Health Care for Their Children With Cerebral Palsy. Qual Health Res. 2015 Aug;25(8):1139-54. doi: 10.1177/1049732315570122. Epub 2015 Feb 23.
- Background: PubMed 12227618Prevalence and characteristics of children with cerebral palsy in Europe. Dev Med Child Neurol. 2002 Sep;44(9):633-40.
- Background: PubMed 26195302Koldoff EA, Holtzclaw BJ. Physical Activity Among Adolescents with Cerebral Palsy: An Integrative Review. J Pediatr Nurs. 2015 Sep-Oct;30(5):e105-17. doi: 10.1016/j.pedn.2015.05.027. Epub 2015 Jul 18.
- Background: PubMed 16772110Krakovsky G, Huth MM, Lin L, Levin RS. Functional changes in children, adolescents, and young adults with cerebral palsy. Res Dev Disabil. 2007 Jul-Sep;28(4):331-40. doi: 10.1016/j.ridd.2006.03.005.
- Background: PubMed 24714702Nooijen C, Slaman J, van der Slot W, Stam H, Roebroeck M, van den Berg-Emons R; Learn2Move Research Group. Health-related physical fitness of ambulatory adolescents and young adults with spastic cerebral palsy. J Rehabil Med. 2014 Jul;46(7):642-7. doi: 10.2340/16501977-1821.
- Background: PubMed 25274143Wingstrand M, Hagglund G, Rodby-Bousquet E. Ankle-foot orthoses in children with cerebral palsy: a cross sectional population based study of 2200 children. BMC Musculoskelet Disord. 2014 Oct 2;15:327. doi: 10.1186/1471-2474-15-327.
- Individual participant dataSharing planned: No
Related trials for Cerebral Palsy
Not yet recruiting
Feasibility of a Robot-Guided Active Play Intervention for Children With Cerebral Palsy
Cerebral Palsy
Recruiting
Additional Effects on tDCS With AOT on Lower Limb Functions on Children With Diplegic CP
Diplegic Cerebral Palsy
Recruiting
Sensory Integration Therapy vs Conventional Physical Therapy in Children With Mixed Cerebral Palsy
Cerebral Palsy
Active, not recruiting
Functional Outcomes and Control Using Synchron BCI - Australia
Neurologic Disorder, Neurologic Diseases
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Dr C Stewart, PhD principal investigator
RJAH Orthopaedic Hospital/Keele University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cerebral Palsy, run by Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 22 Apr 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Dr C Stewart, PhD (0044 1691 404666, caroline.stewart9@nhs.net), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Walking speed (m/s) (time frame: At baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04081675, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Apr 2021.